STOCK TITAN

EMGE Announces Death of President and Founder Dr. John V. Cappello

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Emergent Health Corp. (OTC PINK: EMGE) announced the passing of Dr. John V. Cappello, the company's President and Founder, on February 8, 2022. The Board of Directors expressed deep condolences and reaffirmed confidence in the management team to carry on Dr. Cappello's vision for the company’s nutritional supplement and product development. Emergent Health focuses on natural stem cell mobilizing agents and diet aids, including its newly acquired subsidiary, PharmaZu, which specializes in pet wellness. The company does not claim FDA approval for its products.

Positive
  • Management expresses confidence in continuing Dr. Cappello's vision.
  • Emergent Health's focus on innovative nutritional products.
  • Acquisition of PharmaZu expands market presence in pet wellness.
Negative
  • Loss of a key leadership figure may impact company direction.
  • Uncertainties around future product development and market position.

KING OF PRUSSIA, PA / ACCESSWIRE / February 8, 2022 / Emergent Health Corp., (OTC PINK:EMGE) today issued the following statement: "It is with great sadness that we announce that Dr. John V. Cappello, President and Founder of Emergent Health, has passed away in King of Prussia, PA. The entire EMGE family mourns this loss. On behalf of our Board of Directors, management team, and employees, we extend our deepest sympathies to Dr. Cappello's family. His passion for EMGE's nutritional supplement business was undeniable and his energy remarkable.

Frank Magliochetti, Director of EMGE, issued the following statement on behalf of the Board of Directors: "With the passing of Dr. John Cappello, EMGE has suffered a great personal loss. Notwithstanding that loss, the Board is confident that our management team will capitalize on John's passion and energy for our recently introduced and in-development products and carry on his vision. The Board will continue to consider in a deliberative way how best to maximize EMGE's performance over the long term."

ABOUT EMERGENT HEALTH CORPORATION

Emergent Health Corp. (www.emergenthealthcorp.com) is developing and marketing natural stem cell mobilizing agents and diet aids designed to help control hunger through normal body signals to the brain and stomach for the consumer and professional markets. PharmaZu Inc., its newly acquired subsidiary is a pure play, e-commerce products and service provider focused on the pet pharmacy, vet telehealth, and pet wellness businesses. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease or illness.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

FOR MORE INFORMATION, PLEASE CONTACT:
James Zimbler
info@emergenthealthcorp.com
631-806-1420

SOURCE: Emergent Health Corp.



View source version on accesswire.com:
https://www.accesswire.com/687949/EMGE-Announces-Death-of-President-and-Founder-Dr-John-V-Cappello

FAQ

What happened to the president and founder of Emergent Health Corp. (EMGE)?

Dr. John V. Cappello, President and Founder of Emergent Health Corp. (EMGE), passed away on February 8, 2022.

What does Emergent Health Corp. (EMGE) focus on?

Emergent Health Corp. focuses on developing and marketing natural stem cell mobilizing agents and dietary aids.

What is the significance of Dr. Cappello's passing for Emergent Health Corp. (EMGE)?

Dr. Cappello's passing is a significant loss for Emergent Health, but the Board remains confident in the management team to carry on his vision.

How is Emergent Health Corp. (EMGE) addressing leadership changes?

Emergent Health’s Board of Directors is working to ensure the continuity of the company’s vision and performance despite the leadership change.

What products does Emergent Health Corp. (EMGE) offer?

Emergent Health Corp. offers nutritional supplements and has a focus on products for pet wellness through its subsidiary, PharmaZu.

EMERGENT HEALTH CORP

OTC:EMGE

EMGE Rankings

EMGE Latest News

EMGE Stock Data

597.73k
58.10M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
King of Prussia